Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells

Leukemia

Volumn 23, Issue 12, 2009, Pages 2304-2308

  Nishioka, C ^a,b   Ikezoe, T ^a   Yang, J ^a   Yokoyama, A ^a  

^a KOCHI UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; JANUS KINASE 2; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; STAT5 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; LETTER; METABOLISM; METHODOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; HUMANS; INTERLEUKIN-6; JANUS KINASE 2; LEUKEMIA, MYELOID, ACUTE; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 74049128326     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.163     Document Type: Letter

References (4)

1. Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 1991; 77: 2031-2036.
2. Beghini A, Bellini M, Magnani I, Colapietro P, Cairoli R, Morra E et al. STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascade. Exp Hematol 2005; 33: 682-688. (Pubitemid 40725834)
3. Ray A, Sassone-Corsi P, Sehgal PB. A multiple cytokine-and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Mol Cell Biol 1989; 9: 5537-5547. (Pubitemid 20004372)
4. Siendones E, Barbarroja N, Torres LA, Buend́a P, Velasco F, Dorado G et al. Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: a possible cause for the limited effectiveness of monotherapy with small-molecule inhibitors. Hematol Oncol 2007; 25: 30-37. (Pubitemid 46474312)